02:28:04

Advancing Treatments for Post-Traumatic Stress Disorder

02:53:55

Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence - PM

02:16:56

Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence - AM

02:53:06

Online Controlled Substances Summit: Public Session

57:57

Implementing the RAISE Action Framework

16:49

Food Traceability - Chris Waldrop

02:35:12

Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest: Afternoon Sessions

02:58:13

Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest - Morning Sessions

43:33

RWE Webinar: Considerations Regarding Non-Interventional Studies for Drug and Biological Products

02:17:14

Natural History Studies and Registries in the Development of Rare Disease Treatments - Afternoon

02:41:13

Natural History Studies and Registries in the Development of Rare Disease Treatments - Morning

01:30:01

2024 Annual Public Meeting of the Board of Directors

03:12:20

Qualifying Biomarkers to Support Rare Disease Regulatory Pathways: Afternoon Sessions

02:06:57

Qualifying Biomarkers to Support Rare Disease Regulatory Pathways: Morning Sessions

02:50:49

Advancing Psychedelic Clinical Study Design: Part 2

03:42:58

Advancing Psychedelic Clinical Study Design: Part 1

18:12

Innovations in Regulatory Science Awards 2023 Leadership Award

06:12

Innovations in Regulatory Science Awards 2023 Innovation Award

11:02

Innovations in Regulatory Science Awards 2023 (Advocacy/Policy Award)

05:46

Innovations in Regulatory Science Awards 2023 (Commissioner Remarks)

02:24:14

Front-of-Package Nutrition Labeling Virtual Public Meeting (11.16.2023)

01:27:23

Integrating Clinical Studies in Health Care Delivery: Post-Market Evidence Generation (11.14.23)

03:08:03

Xylazine Meeting October 4, 2023 Part Two

02:43:40

Xylazine Meeting Part One (October 4, 2023)

01:45:04

10.5.23 Strategies for Improving Public Understanding of FDA Regulated Products

01:58:36

Good Clinical Practice Considerations for Clinical Trials Day Two 9.13.23

02:01:40

Good Clinical Practice Considerations for Clinical Trials Day One 9.12.23

02:00:07

RAISE Workshop 11 Lessons Learned & Practical Applications for the Future (6.15.23)

03:20:28

Considerations for Buprenorphine Initiation and Maintenance Care (Day Two)

03:33:42

Considerations for Buprenorphine Initiation and Maintenance Care (Day One)

01:02:44

Real-World Evidence Webinar Series: Externally Controlled Trials

03:47:38

Understanding Fatal Overdoses Public Meeting: Day 2

03:46:33

Understanding Fatal Overdoses Public Meeting - Day 1

10:16

Commissioner Califf remarks at the 2022 Innovations in Regulatory Science Awards December 6, 2022

00:35

COVID-19 Evidence Accelerator: What We've Learned, Where We're Headed

03:00:18

COVID-19 Evidence Accelerator: What We've Learned, Where We're Headed

01:25:13

Tracking and Monitoring of Antimicrobial Use in Food-Producing Animals

03:43

FDA Acting Chief Scientist Jacqueline O'Shaughnessy, PhD, at the 2022 Annual Public Meeting

46:21

FDA Deputy Commissioner Panel Discussion

19:15

FDA Commissioner Robert Califf, MD speaks with Foundation Board Chair Ellen V. Sigal, PhD

01:22:00

2022 Annual Public Meeting

02:15:32

Naloxone Access: Answering Questions Virtual Public Meeting March 29th, 2022

02:59:09

Accelerated Approval Program - 30 Years On: Insights and Experiences Virtual Public Meeting

01:00:18

RWD Live Event February 2022 2 11 22 V1

01:02:56

Real-World Data Webinar: Registries (1.28.2022)

20:32

Awardee Panel from the 2021 Innovations in Regulatory Science Awards

07:01

Acting FDA Commissioner Janet Woodcock speaks at the Innovations in Regulatory Science Awards

59:56

RUF FDA RWE Webinar 12 3 21 V2

29:29

Innovations in Regulatory Science Awards Highlights 2021

01:01:45

Real World Data Webinar: Assessing Electronic Health Records

04:55:01

A Practical Research Agenda for Treatment Development for Stimulant Use Disorder A Public Workshop

04:20:13

COVID-19 Lessons Learned: Clinical Evaluation of Therapeutics Virtual Public Workshop

08:30

Heidi's Vaccine Data Interoperability Story

13:56

Expanded Access discussion at the 2021 FDA Foundation Annual Meeting

11:40

Food & Nutrition work from the FDA Foundation's 2021 Annual Meeting

14:10

The Vaccine Confidence Project discussion at the FDA Foundation's 2021 Annual Public Meeting

13:03

COVID-19 Evidence Accelerator discussion at the FDA Foundation's 2021 Annual Public Meeting

10:52

IMEDS discussion at the FDA Foundation's 2021 Annual Public Meeting

05:08

FDA Chief Scientist RADM Denise Hinton at the FDA Foundation's 2021 Annual Public Meeting

17:33

Acting FDA Commissioner Janet Woodcock at the 2021 FDA Foundation Annual Public Meeting